SynthesisMedicine2019

Risk of dermatologic and mucosal adverse events associated with PD-1/PD-L1 inhibitors in cancer patients: A meta-analysis of randomized controlled trials.

Wenwei Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.